19th Dec 2005 16:24
GlaxoSmithKline PLC19 December 2005 Notification of Transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons I give below details of changes in the interests of Directors, PersonsDischarging Managerial Responsibility or Connected Persons in the OrdinaryShares of GlaxoSmithKline plc. 1 November 2005 Abacus (GSK) Trustees Limited, as trustee of the GlaxoSmithKline Employee Trust, ("the GSK Trust"), sold 1,718 Ordinary Shares in the Company on behalf of participants in the SmithKline Beecham Mid-Term Incentive Plan at a price of £14.6636 per share. The Company was advised of this transaction on 2 November 2005. 16 November 2005 Abacus (GSK) Trustees Limited, as trustee of the GSK Trust, transferred 9,005 Ordinary Shares in the Company to participants in the SmithKline Beecham Employee Share Option Plan 1991. 17 November 2005 Abacus (GSK) Trustees Limited, as trustee of the GSK Trust, transferred 2,470 Ordinary Shares in the Company to participants in the SmithKline Beecham Mid-Term Incentive Plan. The Company was advised of these transactions on 17 November 2005. The GSK Trust is a discretionary trust of which all employees or formeremployees of GlaxoSmithKline plc and its subsidiaries are potentialbeneficiaries. Three of the Company's directors, Dr J-P Garnier, Dr T Yamada andMr J S Heslop are therefore interested in the shares held in the GSK Trust fromtime to time in the same way as other employees or former employees ofGlaxoSmithKline plc and its subsidiaries. This notification relates to a transaction notified in accordance withDisclosure Rule 3.1.4R(1)(b). S M BicknellCompany Secretary 19 December 2005 This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
Glaxosmithkline